{
  "url": "https://openlegislation.uk/eu-decision-2006-430/division-2/2/1/1",
  "json_url": "https://openlegislation.uk/eu-decision-2006-430/division-2/2/1/1.json",
  "legislation": "eudn/2006/430",
  "legislation_title": "Commission Decision of 25 August 2005 declaring a concentration compatible with the common market and the functioning of the EEA Agreement (Case COMP/M.3687 — Johnson & Johnson/Guidant) (notified under document number C(2005) 3230) (Only the English text is authentic) (Text with EEA relevance) (2006/430/EC)",
  "legislation_url": "https://openlegislation.uk/eu-decision-2006-430",
  "path": "division/2/2/1/1",
  "kind": "division",
  "number": "(6)",
  "heading": null,
  "text": "Interventional cardiology devices are designed to treat, through minimally invasive procedures, coronary artery diseases. In this area the main device is the stent, a small expandable wire tube that is placed in an occluded coronary artery to remove the plaque and support the walls of the vessel, thus enabling the blood to flow properly.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eudn/2006/430/division/2/2/1/1",
    "retrieved_at": "2026-11-01T15:17:33.972712+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}